/NOX

NOX

Updated 21 Nov 08:02 am

$0.037

NOXOPHARM LIMITED

1D+2.78%
1M-32.73%
1Y-58.43%
Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Track your position in NOX

Sign in to TradeLedgr to record trades in NOX (NOXOPHARM LIMITED) with broker-true precision and ATO-compliant reporting.

Recent Announcements

19 Nov 2026 9:36 PM
219KB
Change of Director's Interest Notice
Change of Director's Interest Notice
19 Nov 2026 9:36 PM
218KB
Change of Director's Interest Notice
Change of Director's Interest Notice
19 Nov 2026 9:35 PM
241KB
Change of Director's Interest Notice
Change of Director's Interest Notice
19 Nov 2026 9:26 PM
294KB
Cleansing Statement
Cleansing Notice
Appendix 2A

Fundamentals

P/E Ratio

—

Div Yield

0.00%

EPS

$-0.0150

Avg Vol

—

52W High

$0.110

52W Low

$0.032

Company Profile

Noxopharm Limited (ASX:NOX) is an Australian clinical-stage drug development company focused on the treatment of cancer and cytokine release syndrome (septic shock).

Corporate Website

Financial History

2026A

$-4.5M profit

$1.4M rev

2025A

$-4.9M profit

$2.8M rev

2024A

$-3.6M profit

$2.4M rev